1. Ledent C, Dumont JE, Vassart G, Parmentier M 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 11:537-542
2. Maenhaut C, Van Sande J, Libert F, Abramowicz M, Parmentier M, Vanderhaegen JJ, Dumont JE, Vassart G, Schiffmann S 1990 RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173:1169-1178
3. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the Mc Cune-Albright syndrome. New Engl J Med 325:1688-1695
4. Michiels FM, Caillou B, Talbot M, Dessarps Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R, Feunteun J 1994 Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci U S A 91:10488-10492
5. Thomas JS, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC 1982 Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol Copenh 100:512-518
6. Duprez L, Parma J, Van Sande J, Allegeier A, Leclère J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont JE, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause non autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401
7. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski L, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554
8. Fuhrer D, Wonerow P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238
9. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccoli P, Pinchera A, Vitti P 2000 Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab 85:2270-2274
10. Biebermann H, Schoneberg T, Hess C, Germak J, Gudermann T, Gruters A 2001 The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 86:4429-4433
11. Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G, Persani L 2001 A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 145:249-254
12. Khoo DH, Parma J, Rajasoorya C, Ho SC, Vassart G 1999 A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family [see comments]. J Clin Endocrinol Metab 84:1459-1462
13. Lee YS, Poh L, Loke KY 2002 An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism. J Pediatr Endocrinol Metab 15:211-215
14. Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J, Ludgate M 2000 Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 10:1035-1041
15. Aoshima H, Yoshida T, Kobayashi S, Mizushima Y, Kawai S 2000 Genomic DNA analysis of thyrotropin receptor in a family with hereditary hyperthyroidism. Endocr J 47:365-372
16. Esapa CT, Duprez L, Ludgate M, Mustafa MS, Kendall-Taylor P, Vassart G, Harris PE 1999 A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis. Thyroid 9:1005-1010
17. Van Durme J, Horn F, Costagliola S, Vriend G, Vassart G 2006 GRIS: glycoprotein-hormone receptor information system. Mol Endocrinol 20:2247-2255
18. Leclere J, Béné MC, Duprez A, Faure G, Thomas JL, Vignau M, Burlet C 1984 Behavior of thyroid tissue from patients with Graves'disease in nude mice. J Clin Endocrinol Metab 59:175-177
19. Lavard L, Jacobsen BB, Perrild H, Vassart G, Parma J 2004 Prevalence of germline mutations in the TSH receptor gene as a cause of juvenile thyrotoxicosis. Acta Paediatr 93:1192-1194
20. Kopp P, Van Sande J, Parma J, Duprez L, Zuppinger K, Jameson JL, Vassart G 1995 Congenital non-autoimmune hyperthyroidism caused by a neomutation in the thyrotropin receptor gene. New Engl J Med 332:150-154
21. Kohler B, Biebermann H, Krohn HP, Dralle D, Finke R, Gruters A 1996 A novel germline mutation in the TSH receptor gene causing nonautoimmune congenital hyperthyroidism. International Congress of Endocrinology San francisco 1996 Abstract 1:P-946
22. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T 1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431-1436
23. Kopp P, Jameson JL, Roe TF 1997 Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 7:765-770
24. Holzapfel HP, Wonerow P, von Petrykowski W, Henschen M, Scherbaum WA, Paschke R 1997 Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 82:3879-3884
25. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639
26. Karges B, Krause G, Homoki J, Debatin KM, DE Roux N, Karges W 2005 TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J Endocrinol 186:377-385
27. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-696
28. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, et al 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659
29. Goretzki PE, Lyons J, Stacy Phipps S, Rosenau W, Demeure M, Clark OH, McCormick F, Roher HD, Bourne HR 1992 Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J Surg 16:576-581
30. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R 1991 gsp mutations in human thyroid tumours. Oncogene 6:677-679
31. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4:345-349
32. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont JE, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651
33. Gether U, Lin S, Ghanouni P, Ballesteros JA, Weinstein H, Kobilka BK 1997 Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J 16:6737-6747
34. Govaerts C, Lefort A, Costagliola S, Wodak SJ, Ballesteros JA, Van Sande J, Pardo L, Vassart G 2001 A conserved ASN in TM7 is a on/off switch in the activation of the TSH receptor. J Biol Chem
35. Vassart G, Pardo L, Costagliola S 2004 A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29:119-126
36. Porcellini A, Ciullo I, Laviola L, Amabile A, Fenzi G, Avvedimento V 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 79:657-661
37. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789
38. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont JE, Vassart G 1995 Somatic mutations causing constitutive activity of the TSH receptor are the major cause of hyperfunctional thyroid adenomas: identification of additional mutations activating both the cAMP and inisitolphosphate-Ca++ cascades. Mol Endocrinol 9:725-733
39. Wonerow P, Schoneberg T, Schultz G, Gudermann T, Paschke R 1998 Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. J Biol Chem 273:7900-7905
40. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R 1997 Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891
41. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont JE, Vassart G 1997 Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 409:469-474
42. Takeshita A, Nagayama Y, Yokoyama N, Ishikawa N, Ito K, Yamashita T, Obara T, Murakami Y, Kuma K, Takamatsu J, et al 1995 Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab 80:2607-2611
43. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S, et al 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80:1347-1351
44. Parma J, Duprez L, Van Sande J, Hermans J, Van Vliet G, Costagliola S, Rodien P, Dumont JE, Vassart G. Diversity and prevalence of somatic mutations in the TSH receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J.Clin.Endocrinol.Metab. 82, 2695-2701. 1997.
45. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van Sande J, Noguchi S 2002 Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol 147:287-291
46. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G, Parma J 1997 Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab (in press):
47. Tonacchera M, Vitti P, Agretti P, Giulianetti B, Mazzi B, Cavaliere R, Ceccarini G, Fiore E, Viacava P, Naccarato A, Pinchera A, Chiovato L 1998 Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid 8:559-564
48. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoli P, Vitti P 1998 Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J Clin Endocrinol Metab 83:492-498
49. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R 1997 Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 82:4229-4233
50. Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R, Krohn K 2006 Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147:3391-3397
51. Russo D, Arturi F, Schlumberger M, Caillou B, Filetti S, Suarez HG 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11:1907-1911
52. Spambalg D, Sharifi N, Elisei R, Gross JG, Medeiros-Neto G, Fagin AJ 1996 Structural studies of the TSH receptor and Gsa in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab 81:3898-3901
53. Niepomniszcze H, Suarez H, Pitoia F, Pignatta A, Danilowicz K, Manavela M, Elsner B, Bruno OD 2006 Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid 16:497-503
54. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn L 1992 Mutation of Alanine 623 in the third cytoplasmic loop of the rat TSH receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J Biol Chem 267:24153-24156
55. Eggerickx D, Denef JF, Labbe O, Hayashi Y, Refetoff S, Vassart G, Parmentier M, Libert F 1995 Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. Biochem J 309:837-843
56. Westphal RS, Backstrom JR, Sanders Bush E 1995 Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol Pharmacol 48:200-205
57. Tiberi M, Caron MG 1994 High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269:27925-27931
58. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577-2585
59. Samama P, Cotecchia S, Costa T, Lefkowitz RJ 1993 A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636
60. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ 1992 Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267:1430-1433
61. Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S 1993 Constitutively active mutants of the a2-adrenergic receptor. J Biol Chem 268:16483-16487
62. Lefkowitz RJ, Cotecchia S, Samama P, Costa T 1994 Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. TiPS 14:303-307
63. Claus M, Neumann S, Kleinau G, Krause G, Paschke R 2006 Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor. J Mol Med 84:943-954
64. Kleinau G, Claus M, Jaeschke H, Mueller S, Neumann S, Paschke R, Krause G 2007 Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor. J Biol Chem 282:518-525
65. Urizar E, Claeysen S, Deupi X, Govaerts C, Costagliola S, Vassart G, Pardo L 2005 An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor J Biol Chem 280:17135-17141
66. Vlaeminck V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746
67. Zhang M, Tong KP, Fremont V, Chen J, Narayan P, Puett D, Weintraub BD, Szkudlinski MW 2000 The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141:3514-3517
68. Glinoer D 1997 The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18:404-433
69. Burrow GN 1993 Thyroid function and hyperfunction during gestation. Endocr Rev 14:194-202
70. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM 1992 The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333-1337
71. Swaminathan R, Chin RK, Lao TT, Mak YT, Panesar NS, Cockram CS 1989 Thyroid function in hyperemesis gravidarum. Acta Endocrinol (Copenh) 120:155-160
72. Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611
73. Rodien P, Bremont C, Sanson ML, Parma J, Van Sande J, Costagliola S, Luton JP, Vassart G, Duprez L 1998 Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339:1823-1826
74. Kajava AV, Vassart G, Wodak SJ 1995 Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 3:867-877
75. Nagayama Y, Russo D, Chazenbalk GD, Wadsworth HL, Rapoport B 1990 Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. Biochem Biophys Res Commun 173:1150-1156
76. Smits G, Govaerts C, Nubourgh I, Pardo L, Vassart G, Costagliola S 2002 Lysine 183 and glutamic acid 157 of the thyrotropin receptor : two interacting residues with a key role in determining specificity towards TSH and hCG. Mol Endocrinol722-735
77. Fan QR, Hendrickson WA 2005 Structure of human follicle-stimulating hormone in complex with its receptor Nature 433:269-277
78. Mrabet NT, Van den Broeck A, Van den brande I, Stanssens P, Laroche Y, Lambeir AM, Matthijssens G, Jenkins J, Chiadmi M, van Tilbeurgh H 1992 Arginine residues as stabilizing elements in proteins. Biochemistry 31:2239-2253
79. Stewart HJ, Jones DSC, Pascall JC, Popkin RM, Flint APF 1988 The contribution of recombinant DNA technology to reproductive biology. J Reprod Fert 83:1-57
80. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD 2002 Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473-502
81. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S 2003 Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349:760-766
82. Vasseur C, Rodien P, Beau I, Desroches A, Gerard C, de Poncheville L, Chaplot S, Savagner F, Croue A, Mathieu E, Lahlou N, Descamps P, Misrahi M 2003 A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349:753-759
83. Miyai K, Azukizawa M, Kumahara Y 1971 Familial isolated thyrotropin deficiency with cretinism. N Engl J Med 285:1043-1048
84. Hayashizaki Y, Hiraoka Y, Endo Y, Miyai K, Matsubara K 1989 Thyroid-stimulating hormone (TSH) deficiency caused by a single base substitution in the CAGYC region of the beta-subunit [published erratum appears in EMBO J 1989 Nov;8(11):3542]. EMBO J 8:2291-2296
85. Hayashizaki Y, Hiraoka Y, Tatsumi K, Hashimoto T, Furuyama J, Miyai K, Nishijo K, Matsuura M, Kohno H, Labbe A, et al 1990 Deoxyribonucleic acid analyses of five families with familial inherited thyroid stimulating hormone deficiency [see comments]. J Clin Endocrinol Metab 71:792-796
86. Stein SA, Shanklin DR, Krulich L, Roth MG, Chubb CM, Adams PM 1989 Evaluation and characterization of the hyt/hyt hypothyroid mouse. II. Abnormalities of TSH and the thyroid gland. Neuroendocrinology 49:509-519
87. Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S 1994 Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 8:129-138
88. Stanbury JB, Rocmans P, Buhler UK, Ochi Y 1968 Congenital hypothyroidism with impaired thyroid response to thyrotropin. N Engl J Med 279:1132-1136
89. Codaccioni JL, Carayon P, Michel Bechet M, Foucault F, Lefort G, Pierron H 1980 Congenital hypothyroidism associated with thyrotropin unresponsiveness and thyroid cell membrane alterations. J Clin Endocrinol Metab 50:932-937
90. Takeshita A, Nagayama Y, Yamashita S, Takamatsu J, Oshawa N, Maesaka H, Tachibana K, Tokuhiro E, Ashizawa K, Yokoyama N, Nagataki S 1994 Sequence analysis of the TSH receptor gene in congenital primary hypothyroidism associated with TSH unresponsiveness. Thyroid 4:255-259
91. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S 1995 Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. New Engl J Med 332:155-160
92. DE Roux N, Misrahi M, Brauner R, Houang M, Carel JC, Granier M, Le Bouc Y, Ghinea N, Boumedienne A, Toublanc JE, Milgrom E 1996 Four families with loss of function mutations of the thyrotropin receptor. J Clin Endocrinol Metab 81:4229-4235
93. de Bernard S, Misrahi M, Huet JC, Beau I, Desroches A, Loosfelt H, Pichon C, Pernollet JC, Milgrom E 1999 Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain [In Process Citation]. J Biol Chem 274:101-107
94. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs C 1997 Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 99:3018-3024
95. Biebermann H, Schoneberg T, Krude H, Schultz G, Gudermann T, Gruters A 1997 Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 82:3471-3480
96. Gagne N, Parma J, Deal C, Vassart G, Van Vliet G 1998 Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metab 83:1771-1775
97. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, de Felice M, Di Lauro R 2002 Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci U S A 99:15462-15467
98. Dohan O, De l, V, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N 2003 The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77
99. Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, Vigone MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L 2002 Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 87:2549-2555
100. Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, Beck-Peccoz P, Dunlap D, Persani L 2005 Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum Mol Genet 14:2991-3002
101. Xie J, Pannain S, Pohlenz J, Weiss RE, Moltz K, Morlot M, Asteria C, Persani L, Beck-Peccoz P, Parma J, Vassart G, Refetoff S 1997 Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH [see comments]. J Clin Endocrinol Metab 82:3933-3940
102. Grasberger H, Mimouni-Bloch A, Vantyghem MC, Van Vliet G, Abramowicz M, Metzger DL, Abdullatif H, Rydlewski C, Macchia PE, Scherberg NH, Van Sande J, Mimouni M, Weiss RE, Vassart G, Refetoff S 2005 Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: clinical characterization and exclusion of candidate loci. J Clin Endocrinol Metab 90:4025-4034
103. Grasberger H, Vaxillaire M, Pannain S, Beck JC, Mimouni-Bloch A, Vatin V, Vassart G, Froguel P, Refetoff S 2005 Identification of a locus for nongoitrous congenital hypothyroidism on chromosome 15q25.3-26.1. Hum Genet 118:348-355